a prospective, case-controlled study
Conditions
Brief summary
The primary endpoint of both the first and second phase of the study is to investigate the extent to which sevoflurane used to maintain inhalational anaesthesia and propofol used to maintain total intravenous anaesthesia potentiate the pharmacokinetic properties of rocuronium at different doses. The translational clinical utility of this may be that knowledge in this age population will contribute to the safe implementation of reversal of muscle relaxant action.
Interventions
DRUGRocuronium bromide hameln 10 mg/ml oldatos injekció/infúzió
Sponsors
University Of Debrecen
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of both the first and second phase of the study is to investigate the extent to which sevoflurane used to maintain inhalational anaesthesia and propofol used to maintain total intravenous anaesthesia potentiate the pharmacokinetic properties of rocuronium at different doses. The translational clinical utility of this may be that knowledge in this age population will contribute to the safe implementation of reversal of muscle relaxant action. | — |
Countries
Hungary
Outcome results
None listed